TU-100 ( DrugBank: TU-100 )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 96 | クローン病 | 1 |
96. クローン病
臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01388933 (ClinicalTrials.gov) | September 2011 | 5/7/2011 | A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease | A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease | Crohn's Disease | Drug: TU-100;Drug: Matching Placebo | Tsumura USA | INC Research | Terminated | 18 Years | 75 Years | Both | 79 | Phase 2 | United States |